Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2011 1
2012 1
2019 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.
Miyazaki Y, Goto T, Li X, Nakayama K, Okasho K, Takeda M, Mizuno K, Kimura H, Uegaki M, Sumiyoshi T, Teramoto Y, Akamatsu S, Kobayashi T, Ogawa O, Inoue T. Miyazaki Y, et al. Among authors: okasho k. Cancer Med. 2023 Feb;12(3):3328-3342. doi: 10.1002/cam4.5134. Epub 2022 Aug 13. Cancer Med. 2023. PMID: 36812122 Free PMC article.
Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.
Nagai T, Terada N, Fujii M, Nagata Y, Nakahara K, Mukai S, Okasho K, Kamiyama Y, Akamatsu S, Kobayashi T, Iida K, Denawa M, Hagiwara M, Inoue T, Ogawa O, Kamoto T. Nagai T, et al. Among authors: okasho k. Cancer Rep (Hoboken). 2023 Feb;6(2):e1701. doi: 10.1002/cnr2.1701. Epub 2022 Aug 9. Cancer Rep (Hoboken). 2023. PMID: 36806727 Free PMC article.
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.
Sumiyoshi T, Mizuno K, Yamasaki T, Miyazaki Y, Makino Y, Okasho K, Li X, Utsunomiya N, Goto T, Kobayashi T, Terada N, Inoue T, Kamba T, Fujimoto A, Ogawa O, Akamatsu S. Sumiyoshi T, et al. Among authors: okasho k. Sci Rep. 2019 Mar 11;9(1):4030. doi: 10.1038/s41598-019-40719-y. Sci Rep. 2019. PMID: 30858508 Free PMC article.
[Multi-institute survey on actual conditions of urologic management for severe bladder dysfunction after hysterectomy].
Yoshimura K, Kamoto T, Okada T, Kawakita M, Ikeda H, Hayashi T, Yamamoto M, Kanamaru H, Masui K, Okuno H, Aoyama T, Terai A, Higashi S, Nishio Y, Ishitoya S, Okumura K, Nakajima M, Shichiri Y, Ueda T, Oka H, Fukuzawa S, Okamura Y, Nonomura M, Okasho K, Taki Y, Onishi H, Moroi S, Nishimura K, Ito N, Soeda A, Sasaki M, Ito M, Ogura K, Ogawa O. Yoshimura K, et al. Among authors: okasho k. Hinyokika Kiyo. 2008 Jun;54(6):401-5. Hinyokika Kiyo. 2008. PMID: 18634434 Free article. Japanese.
11 results